α'-Methyletonitazene
| Identifiers | |
|---|---|
| |
| Chemical and physical data | |
| Formula | C23H30N4O3 |
| Molar mass | 410.518 g·mol−1 |
| 3D model (JSmol) | |
| |
| |
α'-Methyletonitazene is a benzimidazole derivative which is an opioid designer drug. It was the most potent compound identified in a series of etonitazene analogues tested for structure-activity relationship studies on this emerging class of designer drugs, though was still slightly less potent than etonitazene itself.[1][2][3]
See also
References
- ^ Vandeputte MM, Glatfelter GC, Walther D, Layle NK, St Germaine DM, Ujváry I, et al. (December 2024). "Characterization of novel nitazene recreational drugs: Insights into their risk potential from in vitro μ-opioid receptor assays and in vivo behavioral studies in mice". Pharmacological Research. 210 107503. doi:10.1016/j.phrs.2024.107503. PMC 11655282. PMID 39521025.
- ^ Vandeputte MM, Stove CP (2025). "Navigating nitazenes: A pharmacological and toxicological overview of new synthetic opioids with a 2-benzylbenzimidazole core". Neuropharmacology. 275 110470. doi:10.1016/j.neuropharm.2025.110470. PMID 40252758.
- ^ Stove CP, Vandeputte MM, Glatfelter GC, Walther D, Layle NK, St Germaine DM, et al. (2025). "Nitazenes of the Past, Present, and Future: Insights from in Vitro µ-opioid Receptor Assays and in Vivo Behavioral Studies in Mice (Abstract ID: 162711)". The Journal of Pharmacology and Experimental Therapeutics. 392 (3) 101052. doi:10.1016/j.jpet.2024.101052.